Trifluoperazine Inhibits Mesangial Cell Proliferation by Arresting Cell Cycle-Dependent Mechanisms

Overview

Journal Med Sci Monit

Specialties General Medicine
Pathology

Date 2017 Jul 18

PMID 28713151

Citations 3

Authors

Baodong Wang

Xiaoshuang Zhou

Yanqin Wang

Rongshan Li

Affiliations

Soon will be listed here.

Abstract

BACKGROUND It has been reported that trifluoperazine (TFP) inhibits proliferation of cancer cells, however, the effects of TFP in renal proliferation diseases are still unclear. This study examined the effects of TFP on proliferation of human renal mesangial cells and analyzed the underlying mechanisms. MATERIAL AND METHODS Cell proliferation in vivo was determined by HE staining, immunohistochemistry of proliferating cell nuclear antigen (PCNA), and Western blot analysis (Ki-67 and PCNA). Effects of different TFP concentrations and treatment duration on cell proliferation and cell cycle were analyzed using the MTT assay and flow cytometry. Expression of G0/G1 phase cell cycle-related proteins and TFP-induced MAPK and PI3K/AKT signaling pathways was estimated with Western blot analysis. RESULTS Our findings suggest that TFP inhibits cell proliferation in a dose- and time-dependent manner and decreased PCNA and Ki-67 levels in lupus MRL/lpr mice. TFP arrested the cell cycle in the G0/G1 phase, down-regulating cyclin D1, CDK2, and CDK4, and up-regulating p21 expression in a dose-dependent manner. In addition, TFP inhibited p-AKT and p-JNK, possibly by suppressing the activation of PI3K/AKT and JNK/MAPK signaling pathways. TFP treatment remarkably reduced the levels of serum creatinine (Cr) in lupus mice. CONCLUSIONS TFP exhibits inhibitory activity against mesangial cells in vivo and in vitro, which is associated with G1 cell cycle arrest by inactivation of PI3K/AKT and JNK/MAPK signaling pathways. These results suggest the potential of TFP in treatment of mesangial proliferative diseases.

Citing Articles

The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibition.

Vanneste M, Venzke A, Guin S, Fuller A, Jezewski A, Beattie S Front Oncol. 2023; 13:1295185.

PMID: 37909019 PMC: 10613967. DOI: 10.3389/fonc.2023.1295185.

Mesangial cell: A hub in lupus nephritis.

Liu M, Zhang L, Wang Y, Hu W, Wang C, Wen Z Front Immunol. 2023; 13:1063497.

PMID: 36591251 PMC: 9795068. DOI: 10.3389/fimmu.2022.1063497.

Antipsychotic Drug Trifluoperazine Suppresses Colorectal Cancer by Inducing G0/G1 Arrest and Apoptosis.

Xia Y, Jia C, Xue Q, Jiang J, Xie Y, Wang R Front Pharmacol. 2019; 10:1029.

PMID: 31572198 PMC: 6753363. DOI: 10.3389/fphar.2019.01029.

References

Rodriguez-Barbero A, Dorado F, Velasco S, Pandiella A, Banas B, Lopez-Novoa J . TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells. Kidney Int. 2006; 70(5):901-9. DOI: 10.1038/sj.ki.5001626. View

Li T, Zhao X, Mo Z, Huang W, Yan H, Ling Z . Formononetin promotes cell cycle arrest via downregulation of Akt/Cyclin D1/CDK4 in human prostate cancer cells. Cell Physiol Biochem. 2014; 34(4):1351-8. DOI: 10.1159/000366342. View

Goruppi S, Bonventre J, Kyriakis J . Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J. 2002; 21(20):5427-36. PMC: 129067. DOI: 10.1093/emboj/cdf535. View

Saratlija Novakovic Z, Glavina Durdov M, Puljak L, Saraga M, Ljutic D, Filipovic T . The interstitial expression of alpha-smooth muscle actin in glomerulonephritis is associated with renal function. Med Sci Monit. 2012; 18(4):CR235-40. PMC: 3560831. DOI: 10.12659/msm.882623. View

Lamoureux J, Watson L, Cherrier M, Skog P, Nemazee D, Feeney A . Reduced receptor editing in lupus-prone MRL/lpr mice. J Exp Med. 2007; 204(12):2853-64. PMC: 2118512. DOI: 10.1084/jem.20071268. View

Ke Y, Liu C, Hao J, Lu L, Lu N, Wu Z . Morin inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition. Biomed Pharmacother. 2016; 84:622-627. DOI: 10.1016/j.biopha.2016.09.088. View

Tian J, Wang Y, Liu X, Zhou X, Li R . Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms. Exp Biol Med (Maywood). 2014; 240(7):936-45. PMC: 4935411. DOI: 10.1177/1535370214555666. View

Kriz W, Hahnel B, Hosser H, Ostendorf T, Gaertner S, Kranzlin B . Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. J Am Soc Nephrol. 2003; 14(7):1904-26. DOI: 10.1097/01.asn.0000070073.79690.57. View

Peairs A, Dai R, Gan L, Shimp S, Rylander M, Li L . Epigallocatechin-3-gallate (EGCG) attenuates inflammation in MRL/lpr mouse mesangial cells. Cell Mol Immunol. 2010; 7(2):123-32. PMC: 4001894. DOI: 10.1038/cmi.2010.1. View

10.

Chen D, Li Y, Mei Y, Geng W, Yang J, Hong Q . miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway. Cell Mol Life Sci. 2014; 71(20):4027-42. PMC: 4175047. DOI: 10.1007/s00018-014-1599-y. View

11.

Takano K, Kawasaki Y, Imaizumi T, Matsuura H, Nozawa R, Tannji M . Development of glomerular endothelial cells, podocytes and mesangial cells in the human fetus and infant. Tohoku J Exp Med. 2007; 212(1):81-90. DOI: 10.1620/tjem.212.81. View

12.

Hait W, Grais L, Benz C, Cadman E . Inhibition of growth of leukemic cells by inhibitors of calmodulin: phenothiazines and melittin. Cancer Chemother Pharmacol. 1985; 14(3):202-5. DOI: 10.1007/BF00258116. View

13.

Chen Q, Wu L, Wu Y, Lu G, Jiang Z, Zhan J . Molecular mechanism of trifluoperazine induces apoptosis in human A549 lung adenocarcinoma cell lines. Mol Med Rep. 2011; 2(5):811-7. DOI: 10.3892/mmr_00000177. View

14.

Jiang Y, Cheng D, Levi E, Singh L . IGF-1 increases laminin, cyclin D1, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression. J Cell Biochem. 2006; 98(1):208-20. DOI: 10.1002/jcb.20771. View

15.

Scindia Y, Deshmukh U, Bagavant H . Mesangial pathology in glomerular disease: targets for therapeutic intervention. Adv Drug Deliv Rev. 2010; 62(14):1337-43. PMC: 2992591. DOI: 10.1016/j.addr.2010.08.011. View

16.

Matsumoto K, Yoshikai Y, Asano T, Himeno K, Iwasaki A, Nomoto K . Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J Exp Med. 1991; 173(1):127-36. PMC: 2118754. DOI: 10.1084/jem.173.1.127. View

17.

Reilly C, Mishra N, Miller J, Joshi D, Ruiz P, Richon V . Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid. J Immunol. 2004; 173(6):4171-8. DOI: 10.4049/jimmunol.173.6.4171. View

18.

Schlondorff D, Banas B . The mesangial cell revisited: no cell is an island. J Am Soc Nephrol. 2009; 20(6):1179-87. DOI: 10.1681/ASN.2008050549. View

19.

Qiu L, Sinniah R, Hsu S . Role of differential and cell type-specific expression of cell cycle regulatory proteins in mediating progressive glomerular injury in human IgA nephropathy. Lab Invest. 2004; 84(9):1112-25. DOI: 10.1038/labinvest.3700144. View

20.

Zhou X, Workeneh B, Hu Z, Li R . Effect of immunosuppression on the human mesangial cell cycle. Mol Med Rep. 2014; 11(2):910-6. PMC: 4262500. DOI: 10.3892/mmr.2014.2861. View